Amedisys (NASDAQ: AMED) announced that, on May 21, 2015, it received a Subpoena Duces Tecum (“Subpoena”) issued by the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE